Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2010 1
2011 4
2012 3
2013 9
2014 9
2015 7
2016 16
2017 28
2018 27
2019 28
2020 17
2021 27
2022 20
2023 18
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
STING Agonists as Cancer Therapeutics.
Amouzegar A, Chelvanambi M, Filderman JN, Storkus WJ, Luke JJ. Amouzegar A, et al. Cancers (Basel). 2021 May 30;13(11):2695. doi: 10.3390/cancers13112695. Cancers (Basel). 2021. PMID: 34070756 Free PMC article. Review.
Antithyroid Drugs.
Abdi H, Amouzegar A, Azizi F. Abdi H, et al. Among authors: amouzegar a. Iran J Pharm Res. 2019 Fall;18(Suppl1):1-12. doi: 10.22037/ijpr.2020.112892.14005. Iran J Pharm Res. 2019. PMID: 32802086 Free PMC article. Review.
Tehran Thyroid Study (TTS).
Amouzegar A, Mehran L, Takyar M, Abdi H, Azizi F. Amouzegar A, et al. Int J Endocrinol Metab. 2018 Oct 24;16(4 Suppl):e84727. doi: 10.5812/ijem.84727. eCollection 2018 Oct. Int J Endocrinol Metab. 2018. PMID: 30584429 Free PMC article. Review.
Next-Generation Immunotherapy Approaches in Melanoma.
Buchanan T, Amouzegar A, Luke JJ. Buchanan T, et al. Among authors: amouzegar a. Curr Oncol Rep. 2021 Aug 3;23(10):116. doi: 10.1007/s11912-021-01104-z. Curr Oncol Rep. 2021. PMID: 34342752 Review.
Thyroid Function and Metabolic Syndrome: A Population-Based Thyroid Study.
Mehran L, Amouzegar A, Rahimabad PK, Tohidi M, Tahmasebinejad Z, Azizi F. Mehran L, et al. Among authors: amouzegar a. Horm Metab Res. 2017 Mar;49(3):192-200. doi: 10.1055/s-0042-117279. Epub 2017 Mar 28. Horm Metab Res. 2017. PMID: 28351085 Clinical Trial. English.
Can Supplementation with Vitamin D Modify Thyroid Autoantibodies (Anti-TPO Ab, Anti-Tg Ab) and Thyroid Profile (T3, T4, TSH) in Hashimoto's Thyroiditis? A Double Blind, Randomized Clinical Trial.
Chahardoli R, Saboor-Yaraghi AA, Amouzegar A, Khalili D, Vakili AZ, Azizi F. Chahardoli R, et al. Among authors: amouzegar a. Horm Metab Res. 2019 May;51(5):296-301. doi: 10.1055/a-0856-1044. Epub 2019 May 9. Horm Metab Res. 2019. PMID: 31071734 Clinical Trial.
Long-term thionamide antithyroid treatment of Graves' disease.
Azizi F, Abdi H, Amouzegar A, Habibi Moeini AS. Azizi F, et al. Among authors: amouzegar a. Best Pract Res Clin Endocrinol Metab. 2023 Mar;37(2):101631. doi: 10.1016/j.beem.2022.101631. Epub 2022 Feb 24. Best Pract Res Clin Endocrinol Metab. 2023. PMID: 35440398 Review.
Thyroid disease and the metabolic syndrome.
Mehran L, Amouzegar A, Azizi F. Mehran L, et al. Among authors: amouzegar a. Curr Opin Endocrinol Diabetes Obes. 2019 Oct;26(5):256-265. doi: 10.1097/MED.0000000000000500. Curr Opin Endocrinol Diabetes Obes. 2019. PMID: 31369412 Review.
Secondary and tertiary preventions of thyroid disease.
Azizi F, Mehran L, Hosseinpanah F, Delshad H, Amouzegar A. Azizi F, et al. Among authors: amouzegar a. Endocr Res. 2018 May;43(2):124-140. doi: 10.1080/07435800.2018.1424720. Epub 2018 Jan 10. Endocr Res. 2018. PMID: 29319359 Review.
Primordial and Primary Preventions of Thyroid Disease.
Azizi F, Mehran L, Hosseinpanah F, Delshad H, Amouzegar A. Azizi F, et al. Among authors: amouzegar a. Int J Endocrinol Metab. 2017 Oct 7;15(4):e57871. doi: 10.5812/ijem.57871. eCollection 2017 Oct. Int J Endocrinol Metab. 2017. PMID: 29344036 Free PMC article. Review.
193 results